Advances in the research on lymphangiogenesis in carcinoma tissues (Review)

Oncology Letters

Volumn 1, Issue 4, 2010, Pages 579-582

  Qiu, Xiaofei ^a   Yao, Shujuan ^a   Zhang, S Shiqian ^b  

^a TENGZHOU CENTRAL PEOPLE S HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Carcinoma; Lymphangiogenesis; Lymphatic metastasis; Lymphatic vessel density

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CELL PROTEIN; FIBROBLAST GROWTH FACTOR 2; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; PLATELET DERIVED GROWTH FACTOR; PODOPLANIN; RECEPTOR; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER TISSUE; CARCINOMA; ENDOTHELIUM CELL; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; NONHUMAN; REVIEW; STEM CELL; TUMOR VASCULARIZATION;

EID: 77955006161     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000102     Document Type: Review

References (30)

1. Schacht V, Ramirez MI, Hong YK, et al: T1alpha/podoplanin defciency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBo j 22: 3546-3556, 2003.
2. Schacht V, Dadras SS, johnson LA, jackson DG, Hong YK and Detmar M: up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am j Pathol 166: 913-921, 2005.
3. Wigle JT, Harvey N, Detmar M, et al: An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBo j 21: 1505-1513, 2002.
4. + lymphatic/vascular endothelial precursor cells. Blood 101: 168-172, 2003.
5. He Y, Rajantie I, Ilmonen M, et al: Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64: 3737-3740, 2004.
6. Kerjaschki D: The crucial role of macrophages in lymphangio-genesis.J Clin Invest 115: 2316-2319, 2005.
7. ji RC and Kato S: Lymphatic network and lymphangiogenesis in the gastric wall. j Histochem Cytochem 51: 331-338, 2003.
8. Mattila MM, Ruohola jK, Karpanen T, jackson DG, Alitalo K and Harkonen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int j Cancer 98: 946-951, 2002.
9. Franchi A, Massi D, Santucci M, et al: Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. j Pathol 208: 439-445, 2006.
10. Koike C, McKee TD, Pluen A, et al: Solid stress facilitates spheroid formation: potential involvement of hyaluronan. Br j Cancer 86: 947-953, 2002.
11. Kato S, Shimoda H, ji RC and Miura M: Lymphangiogenesis and expression of specifc molecules as lymphatic endothelial cell markers. Anat Sci Int 81: 71-83, 2006.
12. Maula SM, Luukkaa M, Grenman R, jackson D, jalkanen S and Ristamaki R: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63: 1920-1926, 2003.
13. Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D and Kloppel G: Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am j Pathol 165: 1187-1197, 2004.
14. Padera TP, Kadambi A, di Tomaso E, et al: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886, 2002.
15. Straume o, Jackson DG and Akslen LA: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9: 250-256, 2003.
16. Saintigny P, Kambouchner M, Ly M, et al: Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer 58: 205-213, 2007.
17. Brakenhielm E, Burton jB, johnson M, et al: Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int j Cancer 121: 2153-2161, 2007.
18. Karkkainen MJ, Haiko P, Sainio K, et al: Vascular endothelial growth factor C is required for sprouting of the frst lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80, 2004.
19. Haiko P, Makinen T, Keskitalo S, et al: Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 28: 4843-4850, 2008.
20. Stacker SA, Caesar C, Baldwin ME, et al: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191, 2001.
21. Lin j, Lalani AS, Harding TC, et al: Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65: 6901-6909, 2005.
22. Makinen T, jussila L, Veikkola T, et al: Inhibition of lymp-hangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7: 199-205, 20 01.
23. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA and Silverman JF: Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19: 1317-1323, 2006.
24. Whitehurst B, Flister MJ, Bagaitkar J, et al: Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. Int j Cancer 121: 2181-2191, 2007.
25. Cao R, Bjorndahl MA, Religa P, et al: PDGF-BB induces intra-tumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6: 333-345, 2004.
26. Cao R, Bjorndahl MA, Gallego MI, et al: Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 107: 3531-3536, 2006.
27. Björndahl M, Cao R, Nissen LJ, et al: Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci uSA 102: 15593-15598, 2005.
28. Chang LK, Garcia-Cardena G, Farnebo F, et al: Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci uSA 101: 11658-11663, 2004.
29. Morisada T, Oike Y, Yamada Y, et al: Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105: 4649-4656, 2005.
30. Wang J, Wu K, Zhang D, et al: Expressions and clinical signif-cances of angiopoietin-1, -2 and Tie2 in human gastric cancer. Biochem Biophys Res Commun 337: 386-393, 2005.